ClinicalTrials.gg
CompletedNCT07229885Updated Nov 17, 2025

Comparison of Early Versus Late Trophic Feeding

An interventional study of Early trophic feeding and Late trophic feeding in Very Low Birth Weight Infant, sponsored by RESnTEC, Institute of Research. Completed at 1 site in Pakistan. Open to participants aged 1 Day to 30 Days. Per ClinicalTrials.gov, last updated 2025-11-17.

Sponsored by RESnTEC, Institute of Research · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled May 2025, registered Sep 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
1 Day to 30 Days
Sex
All
01

Study summary

Local data on the neonatal outcomes in early versus late trophic feeding in preterm very low birth weight neonates in terms of mean hospital stay is scarce. Therefore, the current study was planned with the objective of comparing the neonatal outcomes in early versus late trophic feeding in preterm very low birth weight neonates in terms of mean hospital stay.

Read the detailed description

Since preterm, very low birth weight births are common in society, an effective treatment modality is needed at the moment. Evaluating the length of hospital stay and occurrence of necrotizing enterocolitis in preterm very low birth weight neonates with respect to two approaches of trophic feeding in local settings will provide an insight into a better implementation of preventive strategies, resulting in reducing the hospital stays and the incidence of necrotizing enterocolitis, and hence reducing the burden on the already meager resources.

02

Conditions studied

  • Very Low Birth Weight Infant

Browse trials for

03

In context

Birth Weight

185 studies on the registry are indexed under Birth Weight; 24 are open to participants now.

This study's enrollment of 60 is below the median of 170 across 117 interventional studies indexed under Birth Weight.

Browse Birth Weight studies →

Lead sponsor

RESnTEC, Institute of Research is the lead sponsor of 16 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 30 Days
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any gender
  • Neonates aged 1-30 days
  • Preterm very low birth weight neonates

Exclusion criteria

Exclusion Criteria:

  • Neonates transferred from other hospital and already started on antibiotics.
  • Neonates with congenital anomalies, hypoxic ischemic encephalopathy, central nervous system (CNS) impairment, neonatal sepsis, urinary tract infection, or one of twins or higher order multiples (on history and medical record).
  • Non-consenting parents.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Early trophic feeding group

    Infants will receive trophic (enteral) feeding within the first 48 hours after birth.

    Dietary Supplement: Early trophic feeding

  • Experimental
    Late trophic feeding group

    Infants will receive trophic (enteral) feeding after 72 hours after birth.

    Dietary Supplement: Late trophic feeding

Interventions

  • Dietary supplementEarly trophic feeding

    Infants will receive trophic (enteral) feeding within the first 48 hours after birth.

  • Dietary supplementLate trophic feeding

    Infants will receive trophic (enteral) feeding within the first 72 hours after birth.

06

What researchers measure

Primary outcomes

  1. Incidence of necrotizing enterocolitis

    Confirmation of the occurrence of necrotizing enterocolitis based on modified Bell's diagnostic criteria

    Time frame: Up to 30 days

Secondary outcomes

  1. Hospital stay

    Total days from admission till final outcome (discharge/death due to any case).

    Time frame: through study completion, an average of 1 month

07

Study locations

1 site
  • Nishtar Hospital
    Multan, Punjab Province 66000, Pakistan
08

References and documents

Individual participant data

Plan to share: Undecided — Data can be shared on a reasonable request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2025 to primary completion in Oct 2025, 4 months.

Of 43 non-industry interventional studies with no phase under Birth Weight, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 36. This study's 4 months is below that.

Counting every sponsor, half of 44 studies reached it within 19 months; a quarter within 15 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2025
First posted
Nov 17, 2025
StartActual
May 15, 2025
Primary completionActual
Oct 1, 2025
CompletionActual
Oct 1, 2025
Last update
Nov 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07229885
Lead sponsor
RESnTEC, Institute of Research
Responsible party
Muhammad Aamir Latif (Research Consultant, RESnTEC, Institute of Research) — Principal investigator
First posted
Nov 17, 2025
Start date
May 15, 2025
Primary completion
Oct 1, 2025
Completion
Oct 1, 2025
Last update
Nov 17, 2025

Study contacts

Nadeem Akram
principal investigator · Nishter Hospital Multan, Pakistan
Sulaiman Ali, FCPS
study director · Nishter Hospital Multan, Pakistan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion